default author photo

Jesus Maria Banales

Biogipuzkoa Health Research Institute

San Sebastián

Spain

SCHOLARLY PAPERS

1

DOWNLOADS

70

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Anticancer Activity of RAS-GTP Inhibition in Cholangiocarcinoma

Number of pages: 56 Posted: 04 Jul 2025
University of Navarra, University of Navarra, University of Navarra, Revolution Medicines Inc, Revolution Medicines Inc, Vall d’Hebron Institute of Oncology (VHIO), University of Navarra, University of Navarra, University of Navarra, University of Navarra, Vall d’Hebron Institute of Oncology (VHIO), Revolution Medicines Inc, University of Salamanca - CSIC, Cancer Research Center, Biogipuzkoa Health Research Institute, Vall d’Hebron Institute of Oncology (VHIO), Universidad de Navarra - Clinica Universidad de Navarra and Program in Solid Tumors (CIMA), Revolution Medicines Inc, University of Navarra, Vall d’Hebron Institute of Oncology (VHIO), Revolution Medicines Inc, Revolution Medicines Inc, Revolution Medicines Inc, University of Navarra and Independent
Downloads 70 (883,195)

Abstract:

Loading...

cholangiocarcinoma, KRAS oncogene, RAS-GTP inhibitors, resistance